| Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease D Gomez-Almaguer, GJ Ruiz-Argüelles, L del Carmen Tarín-Arzaga, ... Biology of Blood and Marrow Transplantation 14 (1), 10-15, 2008 | 111 | 2008 |
| Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults D Gómez-Almaguer, MA Herrera-Rojas, JC Jaime-Pérez, ... Blood, The Journal of the American Society of Hematology 123 (25), 3906-3908, 2014 | 102 | 2014 |
| Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias D Gómez-Almaguer, M Solano-Genesta, L Tarín-Arzaga, ... Blood, The Journal of the American Society of Hematology 116 (23), 4783-4785, 2010 | 95 | 2010 |
| Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience D Gómez-Almaguer, GJ Ruiz-Argüelles, L del Carmen Tarín-Arzaga, ... Biology of Blood and Marrow Transplantation 9 (3), 157-161, 2003 | 92 | 2003 |
| Danazol as first-line therapy for aplastic anemia JC Jaime-Pérez, PR Colunga-Pedraza, CD Gómez-Ramírez, ... Annals of hematology 90 (5), 523-527, 2011 | 85 | 2011 |
| High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia D Gómez‐Almaguer, L Tarín‐Arzaga, B Moreno‐Jaime, JC Jaime‐Pérez, ... European journal of haematology 90 (6), 494-500, 2013 | 74 | 2013 |
| Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? GJ Ruiz-Argüelles, LC Tarin-Arzaga, ML Gonzalez-Carrillo, ... Bone marrow transplantation 42 (1), 23-28, 2008 | 66 | 2008 |
| Current approaches for the treatment of autoimmune hemolytic anemia JC Jaime-Pérez, M Rodríguez-Martínez, A Gómez-de-León, ... Archivum immunologiae et therapiae experimentalis 61 (5), 385-395, 2013 | 48 | 2013 |
| Topiramate as an adjunctive treatment in migraine prophylaxis HR Martínez, O Londoño, L Cantú‐Martínez, L Carmen Tarín, CD Castillo Headache: The Journal of Head and Face Pain 43 (10), 1080-1084, 2003 | 46 | 2003 |
| Outpatient allografting using non-myeloablative conditioning: the Mexican experience OG Cantú-Rodríguez, JC Jaime-Pérez, CH Gutiérrez-Aguirre, ... Bone marrow transplantation 40 (2), 119-123, 2007 | 45 | 2007 |
| Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia D Gómez-Almaguer, JC Jaime-Pérez, V Garza-Rodríguez, ... Annals of hematology 89, 299-303, 2010 | 36 | 2010 |
| Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience GJ Ruiz-Argüelles, A Morales-Toquero, B López-Martínez, L Tarín-Arzaga, ... Bone Marrow Transplantation 36 (8), 715-720, 2005 | 32 | 2005 |
| Low incidence and severity of graft‐versus‐host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced‐intensity … OG Cantú‐Rodríguez, CH Gutiérrez‐Aguirre, JC Jaime‐Pérez, ... European Journal of Haematology 87 (6), 521-530, 2011 | 31 | 2011 |
| Impact of the affordability of novel agents in patients with multiple myeloma: real‐world data of current clinical practice in Mexico L Tarín‐Arzaga, D Arredondo‐Campos, V Martínez‐Pacheco, ... Cancer 124 (9), 1946-1953, 2018 | 29 | 2018 |
| Outcomes of adolescents and young adults with acute myeloid leukemia treated in a single Latin American center JC Jaime-Pérez, JR Padilla-Medina, LT Fernández, JL Herrera-Garza, ... Clinical Lymphoma Myeloma and Leukemia 18 (4), 286-292, 2018 | 29 | 2018 |
| CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value M Solano-Genesta, L Tarín-Arzaga, I Velasco-Ruiz, JA Lutz-Presno, ... Hematology 17 (2), 66-70, 2012 | 29 | 2012 |
| Umbilical cord blood transplantation using non-myeloablative conditioning: The Mexican experience C Mancias-Guerra, GJ Ruiz-Delgado, C Manzano, MA Diaz-Hernandez, ... Hematology 11 (5-6), 355-359, 2006 | 27 | 2006 |
| Umbilical cord blood transplantation using non-myeloablative conditioning: The Mexican experience C Mancias-Guerra, GJ Ruiz-Delgado, C Manzano, MA Diaz-Hernandez, ... Hematology 11 (5-6), 355-359, 2006 | 27 | 2006 |
| Therapeutic choices in patients with Ph1 (+) chronic myelogenous leukemia living in México in the tyrosine kinase inhibitors (TKI) era: Stem cell transplantation or TKIs GJ Ruiz-Argüelles, LC Tarín-Arzaga, ML González-Carrillo, ... Bone Marrow Transplant 42, 23-28, 2008 | 26 | 2008 |
| Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience CH Gutierrez-Aguirre, OG Cantú-Rodríguez, O Gonzalez-Llano, ... Hematology 12 (3), 193-197, 2007 | 26 | 2007 |
